ESC Professional Premium Access

Precision approaches to defining susceptibility to atrial fibrillation determine risk of cardioembolic stroke.

Congress Session

About the speaker

Doctor Parag Ravindra Gajendragadkar

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
1 presentation
0 follower

3 more presentations in this session

CKD-510, A Non-hydroxamic Acid Hdac6 Inhibitor, For Treatment Of Atrial Fibrillation.

Speaker: Doctor J. Lee (Yongin, KR)

Thumbnail

Ventricular Arrhythmic Risk Prediction in Low- and Moderate-risk Populations Using a Single-Lead ECG Heartbeat.

Speaker: Doctor J. Ramirez (Zaragoza, ES)

Thumbnail

The PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes.

Speaker: Assistant Professor G. Claessen (Leuven, BE)

Thumbnail

Access the full session

Basic and Translational Late-Breaking Science 2

Speakers: Doctor P. Gajendragadkar, Doctor J. Lee, Doctor J. Ramirez, Assistant Professor G. Claessen
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk